Skip to main content

Concert Pharmaceuticals Short Interest Ratio and Short Volume

+0.06 (+1.54 %)
(As of 05/14/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume279,497 shs
Average Volume440,376 shs
Market Capitalization$127.09 million
P/E RatioN/A
Dividend YieldN/A

Short Interest

Concert Pharmaceuticals (NASDAQ:CNCE) Short Interest Data

Current Short Volume1,140,000 shares
Previous Short Volume779,500 shares
Change Vs. Previous Month+46.25%
Dollar Volume Sold Short$5.39 million
Short Interest Ratio / Days to Cover2.2
Last Record DateApril, 15 2021
Outstanding Shares23,800,000 shares
Percentage of Shares Shorted3.54%
Today's Trading Volume279,497 shares
Average Trading Volume440,376 shares
Today's Volume Vs. Average-36.53%

Short Interest Over Time

Concert Pharmaceuticals (NASDAQ:CNCE) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/20211,140,000 shares $5.39 million +46.3%N/A2.2 $4.73
3/31/2021779,500 shares $3.79 million +15.8%N/A1.5 $4.86
3/15/2021672,900 shares $4.29 million -3.7%N/A1.5 $6.37
2/26/2021698,700 shares $4.80 million +19.4%N/A1.6 $6.87
2/12/2021585,100 shares $4.36 million -39.2%N/A1.4 $7.45
1/29/2021961,500 shares $10.44 million +14.0%N/A2.7 $10.86
1/15/2021843,200 shares $10.42 million +7.3%N/A4.8 $12.36
12/31/2020786,000 shares $9.96 million +13.2%N/A5 $12.67
12/15/2020694,200 shares $8.91 million -13.0%N/A4.4 $12.84
11/30/2020798,000 shares $9.07 million +3.8%N/A5.6 $11.37
11/15/2020769,000 shares $8.47 million +11.7%N/A5.9 $11.01
10/30/2020688,400 shares $7.39 million -4.5%N/A5.3 $10.74
10/15/2020721,000 shares $8.11 million +1.4%N/A5.6 $11.25
9/30/2020711,300 shares $6.98 million -4.7%N/A5.9 $9.82
9/15/2020746,400 shares $7.74 million -2.0%N/A6.1 $10.37
8/31/2020761,500 shares $7.33 million +2.2%N/A6.3 $9.62
8/14/2020744,900 shares $7.58 million -1.7%N/A5.9 $10.17
7/31/2020757,700 shares $7.02 million -2.7%N/A5.8 $9.27
7/15/2020778,500 shares $8.23 million +1.6%N/A5.6 $10.57
6/30/2020766,200 shares $7.62 million +27.6%N/A5.2 $9.95
6/15/2020600,600 shares $5.96 million -1.4%N/A4.2 $9.93
5/29/2020609,000 shares $6.25 million +7.0%N/A3.8 $10.27
5/15/2020569,400 shares $4.49 million -0.2%N/A3.4 $7.88
4/30/2020570,700 shares $6.47 million -2.5%N/A3.3 $11.34
4/15/2020585,100 shares $5.72 million -5.1%N/A3 $9.78

Concert Pharmaceuticals (NASDAQ:CNCE) Short Interest FAQ

speech bubbles
speech bubbles

What is Concert Pharmaceuticals' current short interest?

Short interest is the volume of Concert Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 1,140,000 shares of CNCE short.

What is a good short interest ratio for Concert Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Concert Pharmaceuticals currently has a short interest ratio of 2.0.

Is Concert Pharmaceuticals' short interest increasing or decreasing?

Concert Pharmaceuticals saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 1,140,000 shares, an increase of 46.2% from the previous total of 779,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Concert Pharmaceuticals' short interest compare to its competitors?

0.00% of Concert Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Concert Pharmaceuticals: Verastem, Inc. (0.00%), Altimmune, Inc. (0.00%), Basilea Pharmaceutica AG (0.00%), Viking Therapeutics, Inc. (16.13%), Athenex, Inc. (16.83%), Neoleukin Therapeutics, Inc. (0.00%), Hookipa Pharma Inc (0.00%), Geron Co. (0.00%), Provention Bio, Inc. (0.00%), and AC Immune SA (3.32%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Analog Devices, Inc. ($5.85 billion), Aon plc ($5.61 billion), Charter Communications, Inc. ($5.44 billion), Snap Inc. ($3.49 billion), Airbnb, Inc. ($3.35 billion), Peloton Interactive, Inc. ($2.53 billion), ViacomCBS Inc. ($2.48 billion), Expedia Group, Inc. ($2.39 billion), The Kroger Co. ($2.26 billion), and Nuance Communications, Inc. ($2.18 billion). View all of the most shorted stocks.

What does it mean to sell short Concert Pharmaceuticals stock?

Short selling CNCE is an investing strategy that aims to generate trading profit from Concert Pharmaceuticals as its price is falling. Concert Pharmaceuticals' stock is trading up $0.06 today. To short Concert Pharmaceuticals stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Concert Pharmaceuticals will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Concert Pharmaceuticals?

A short squeeze for Concert Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CNCE, which in turn drives the price of the stock up even further.

How often is Concert Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CNCE, twice per month. The most recent reporting period available is April, 15 2021.

This page was last updated on 5/16/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.